Cargando…

Axillary staging in breast cancer patients treated with neoadjuvant chemotherapy in two Dutch phase III studies

BACKGROUND: Primary aim of our study was to assess the impact of timing of sentinel node procedure, pre- versus post-neoadjuvant chemotherapy, on final pathologic node-negative rate (pN0) in patients with clinically node-negative (cN0) breast cancer. Secondary endpoint was the usability of the senti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vriens, Birgit E.P., Keymeulen, Kristien B.M., Kroep, Judith R., Charehbili, Ayoub, Peer, Petronella G., de Boer, Maaike, Aarts, Maureen J.B., Heuts, Esther M., Tjan-Heijnen, Vivianne C.G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Clinical Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542292/ https://www.ncbi.nlm.nih.gov/pubmed/28177921 http://dx.doi.org/10.18632/oncotarget.15101

Ejemplares similares

The correlation of age with chemotherapy-induced ovarian function failure in breast cancer patients
por: Vriens, Ingeborg J.H., et al.
Publicado: (2017)

What to Do with Non-visualized Sentinel Nodes? A Dutch Nationwide Survey Study
por: Verheuvel, Nicole C., et al.
Publicado: (2017)

Different outcome in node-positive breast cancer patients found by axillary ultrasound or sentinel node procedure
por: Verheuvel, Nicole C., et al.
Publicado: (2017)

The trans-DATA study: aims and design of a translational breast cancer prognostic marker identification study
por: de Ruijter, Tim C., et al.
Publicado: (2019)

Efficacy of anastrozole after tamoxifen in early breast cancer patients with chemotherapy‐induced ovarian function failure
por: van Hellemond, Irene E.G., et al.
Publicado: (2019)

The implementation of CDK 4/6 inhibitors and its impact on treatment choices in HR+/HER2− advanced breast cancer patients: A study of the Dutch SONABRE Registry
por: Meegdes, Marissa, et al.
Publicado: (2021)

Direct Medical Costs of Advanced Breast Cancer Treatment: A Real-World Study in the Southeast of The Netherlands
por: Schneider, Paul Peter, et al.
Publicado: (2021)

Clinical value of contralateral breast cancers detected by pre-operative MRI in patients diagnosed with DCIS: a population-based cohort study
por: Keymeulen, Kristien B. I. M., et al.
Publicado: (2022)

Assessment and management of bone health in women with early breast cancer receiving endocrine treatment in the DATA study
por: van Hellemond, Irene E.G., et al.
Publicado: (2019)

Population‐based study of the effect of preoperative breast MRI on the surgical management of ductal carcinoma in situ
por: Keymeulen, K. B. I. M., et al.
Publicado: (2019)

The value of completion axillary treatment in sentinel node positive breast cancer patients undergoing a mastectomy: a Dutch randomized controlled multicentre trial (BOOG 2013-07)
por: van Roozendaal, L. M., et al.
Publicado: (2015)

The role of MRI in axillary lymph node imaging in breast cancer patients: a systematic review
por: Kuijs, V. J. L., et al.
Publicado: (2015)

The role of histological subtype in hormone receptor positive metastatic breast cancer: similar survival but different therapeutic approaches
por: Lobbezoo, Dorien, et al.
Publicado: (2016)

A randomised controlled phase II trial of pre-operative celecoxib treatment reveals anti-tumour transcriptional response in primary breast cancer
por: Brandão, Rita D, et al.
Publicado: (2013)

Improved survival for sequentially as opposed to concurrently delivered neoadjuvant chemotherapy in non-metastatic breast cancer
por: Vriens, B. E. P. J., et al.
Publicado: (2017)

Healthcare Use during the Last Six Months of Life in Patients with Advanced Breast Cancer
por: Schmitz, Renée. S. J. M., et al.
Publicado: (2021)

Breast cancer outcome in relation to bone mineral density and bisphosphonate use: a sub-study of the DATA trial
por: van Hellemond, Irene E. G., et al.
Publicado: (2020)

Prediction of Primary Tumour and Axillary Lymph Node Response to Neoadjuvant Chemo(Targeted) Therapy with Dedicated Breast [18F]FDG PET/MRI in Breast Cancer
por: de Mooij, Cornelis M., et al.
Publicado: (2023)

Can Zoledronic Acid be Beneficial for Promoting Tumor Response in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy?
por: Charehbili, Ayoub, et al.
Publicado: (2013)

Cost and cost-effectiveness of adjuvant trastuzumab in the real world setting: A study of the Southeast Netherlands Breast Cancer Consortium
por: Seferina, Shanly C., et al.
Publicado: (2017)

Trends in Overall Survival and Treatment Patterns in Two Large Population-Based Cohorts of Patients with Breast and Colorectal Cancer
por: van Abbema, Doris, et al.
Publicado: (2019)

Geriatric screening tools are of limited value to predict decline in functional status and quality of life: results of a cohort study
por: Deckx, Laura, et al.
Publicado: (2015)

Extended adjuvant aromatase inhibition after sequential endocrine therapy in postmenopausal women with breast cancer: follow-up analysis of the randomised phase 3 DATA trial
por: Tjan-Heijnen, Vivianne C.G., et al.
Publicado: (2023)

Breast MRI increases the number of mastectomies for ductal cancers, but decreases them for lobular cancers
por: Lobbes, Marc B.I., et al.
Publicado: (2017)

Current Status of Extended Adjuvant Endocrine Therapy in Early Stage Breast Cancer
por: van Hellemond, Irene E. G., et al.
Publicado: (2018)

Survival before and after the introduction of pertuzumab and T-DM1 in HER2-positive advanced breast cancer, a study of the SONABRE Registry
por: Ibragimova, Khava I. E., et al.
Publicado: (2021)

Added value of dedicated axillary hybrid 18F-FDG PET/MRI for improved axillary nodal staging in clinically node-positive breast cancer patients: a feasibility study
por: van Nijnatten, Thiemo J. A., et al.
Publicado: (2017)

CD44 enhances tumor aggressiveness by promoting tumor cell plasticity
por: Paulis, Yvette W.J., et al.
Publicado: (2015)

Avelumab for advanced Merkel cell carcinoma in the Netherlands: a real-world cohort
por: Levy, Sonja, et al.
Publicado: (2020)

Variability of cost trajectories over the last year of life in patients with advanced breast cancer in the Netherlands
por: Schneider, Paul P., et al.
Publicado: (2020)

Occult Breast Cancer due to Multiple Calcified Hamartomas in a Patient with Cowden Syndrome
por: Gómez García, E. B., et al.
Publicado: (2012)

Prognostic DNA methylation markers for hormone receptor breast cancer: a systematic review
por: de Ruijter, Tim C., et al.
Publicado: (2020)

SUBMIT: Systemic therapy with or without up front surgery of the primary tumor in breast cancer patients with distant metastases at initial presentation
por: Ruiterkamp, Jetske, et al.
Publicado: (2012)

Characteristics of triple-negative breast cancer
por: de Ruijter, Tim C., et al.
Publicado: (2010)

Frequency and diagnostic outcome of bilateral recall at screening mammography
por: Lameijer, Joost R. C., et al.
Publicado: (2020)

Changes in breast cancer treatment during the COVID-19 pandemic: a Dutch population-based study
por: Eijkelboom, Anouk H., et al.
Publicado: (2022)

The bachelor-master structure (two-cycle curriculum) according to the Bologna agreement: a Dutch experience
por: Kuks, Jan B.M.
Publicado: (2010)

Development of indicators for patient-centred cancer care
por: Ouwens, Mariëlle, et al.
Publicado: (2009)

Estrogen and progesterone receptor expression levels do not differ between lobular and ductal carcinoma in patients with hormone receptor-positive tumors
por: Truin, Wilfred, et al.
Publicado: (2017)

A cohort study on the evolution of psychosocial problems in older patients with breast or colorectal cancer: comparison with younger cancer patients and older primary care patients without cancer
por: Deckx, Laura, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_mde9rtlqhuc8mevblftq8u5int